- Title
- Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil
- Creators
- Gina M Capiaux - Graduate School of Medical Sciences, Cornell University, New York, NY 10021, United StatesTulin BUDAK-ALPDOGAN - Program of Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, United StatesNaoko Takebe - Program of Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, United StatesPhilipp MAYER-KUCKUK - Program of Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, United StatesDebabrata Banerjee - Program of Molecular Pharmacology and Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, United StatesFrank Maley - New York State Department of Health, Wadsworth Center, Albany, NY 12201, United StatesJoseph R Bertino - Graduate School of Medical Sciences, Cornell University, New York, NY 10021, United States
- Publication Details
- Human gene therapy, Vol.14(5), pp.435-446
- Date published
- 2003
- Publisher
- Liebert
- Academic Unit
- Pharmacology (RWJMS); Bertino Office
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031665527304646
Journal article
Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil
Human gene therapy, Vol.14(5), pp.435-446
2003
PMID: 12691609
Metrics
9 Record Views